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Abstract:	   	  
We	   report	   a	   case	   of	   a	   55-­‐year-­‐old	   woman	   who	   was	   evaluated	   for	   multiple	   episodes	   of	   late	  
postprandial	  hypoglycaemia.	  We	  diagnosed	  her	  condition	  as	   insulin	  autoimmune	  syndrome	  (Hirata	  
disease)	  because	  of	  a	  high	  insulin	  autoantibody	  (IAA)	  titre	  in	  association	  with	  high	  levels	  of	  plasmatic	  
insulin	  and	  hypoglycaemia	  in	  a	  patient	  with	  no	  history	  of	  exogenous	  insulin	  administration	  and	  the	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Introduction	  
Insulin	  autoimmune	  syndrome	  (IAS)	  is	  defined	  by	  the	  presence	  of	  hypoglycaemia	  and	  autoantibodies	  
against	   endogenous	   insulin	   in	   subjects	  without	   a	   history	  of	   exogenous	   insulin	   administration.	   This	  
disorder	  was	  first	  described	  in	  Japan	  by	  Hirata	  et	  al.	  in	  19701.	  The	  prevalence	  of	  the	  syndrome	  is	  still	  
unknown;	  the	  majority	  of	  the	  cases	  were	  described	  in	  Japan,	  where	  244	  cases	  were	  detected	  in	  the	  
period	  1970–19972.	  To	  date,	  it	  represents	  the	  third	  leading	  cause	  of	  hypoglycaemic	  disorder	  in	  that	  
country2.	  This	  disorder	  is	  even	  more	  uncommon	  in	  non-­‐Asian	  people,	  and	  few	  cases	  are	  described	  in	  
the	   European	   and	   American	   literature3.	   In	   this	   paper,	   we	   report	   a	   case	   of	   Hirata	   disease	   in	   a	  
middle-­‐aged	  Italian	  woman.	  
	  
Case	  report	   	  
A	   55-­‐year-­‐old	   woman	   was	   referred	   to	   our	   clinic	   with	   metabolic	   syndrome.	   Routine	   blood	  
examinations	  done	  3	  weeks	  before	  showed	  mild	  hyperinsulinaemia,	  impaired	  glucose	  tolerance	  and	  
hypercholesterolaemia,	  and	  a	  glycosylated	  haemoglobin	  of	  45	  mmol/l.	   She	  had	  a	   family	  history	  of	  
diabetes	  mellitus.	  She	  had	  never	  smoked	  or	  drunk	  alcohol	  and	  had	  no	  allergies.	  She	  had	  a	  history	  of	  
a	   thrombophilic	   syndrome	   (factor	   V	   Leiden	   heterozygote	   mutation)	   and	   postmenopausal	  
osteoporosis.	  She	  had	  no	  history	  of	  diabetes,	  gastric	  surgery	  or	  pancreatic	  disorders.	  She	  had	  been	  
taking	  aspirin	  and	  alendronate.	  She	  had	  never	  taken	  insulin	  or	  other	  oral	  hypoglycaemic	  agents.	   	  
Her	  weight	  was	  84	  kg,	  body	  mass	  index	  34.5	  kg/m2	  and	  waist	  circumference	  103	  cm,	  consistent	  with	  
a	  diagnosis	  of	  metabolic	  syndrome.	  Otherwise,	  her	  physical	  examination	  was	  normal.	  
The	  patient	  was	  discharged	  with	  nutritional	  and	  lifestyle	  change	  advice.	  In	  the	  following	  months,	  she	  
began	   suffering	   from	   general	   fatigue,	   dizziness	   and	   palpitations	   that	   occurred	   about	   three	   hours	  
after	   meals.	   A	   random	  measurement	   of	   capillary	   glycaemia	   during	   symptoms	   revealed	   a	   glucose	  
level	  of	  40	  mg/dl.	  
Laboratory	  evaluation	  revealed	  normal	  blood	  cell	  counts,	  blood	  chemistry	  and	  fasting	  glucose.	  She	  
also	   had	   normal	   levels	   of	   adrenocorticotropic	   hormone	   (ACTH),	   cortisol,	   thyroid-­‐stimulating	  
hormone	   (TSH)	   and	   glycosylated	   haemoglobin,	   but	   abnormally	   high	   levels	   of	   fasting	   insulin	   and	  
c-­‐peptide	  (Table	  1).	  No	  abnormalities	  were	  detected	  in	  any	  other	  autoimmunity	  markers	  (Table	  1).	  
The	   association	   of	   hyperinsulinism,	  weight	   gain	   and	   hypoglycaemia	   suggested	   the	   presence	   of	   an	  
insulinoma.	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   Normal	  range	   	  
White	  blood	  cells	   6980/mmc	   4,000–11,000/mmc	  
Haemoglobin	   13.4	  g/dl	   12–16	  g/dl	  
Platelets	   260,000/mmc	   150,000-­‐400,000	  mmc	  
Fasting	  insulin	   72μUI/ml	   3–25	  μUI/ml	  
Fasting	  C-­‐peptide	   2.53	  ng/ml	   0.81–3.85	  ng/ml	  
8:00	  a.m.	  cortisol	   549	  nmol/l	   150–650	  nmol/l	  
ACTH	   40	  pg/ml	   5–49	  pg/ml	  
HbA1c	  (HPLC)	   45	  mmol/mol	   <48	  mmol/mol	  
Polymerization	  chain	  reaction	   3.32	  mg/l	   0–5	  mg/l	  
Antinuclear	  antibodies	   Absent	   –	  
Anti-­‐dsDNA	   Absent	   –	  
Extractable	  nuclear	  antigen	   Absent	   –	  
Anti-­‐SCL-­‐70	   Absent	   –	  
Anti-­‐surreal-­‐gland	   Absent	   –	  
Anti-­‐GAD	   Absent	   –	  
Anti-­‐iiInsulin	  receptor	   Absent	   –	  
Anti-­‐insulin	   	   >100	  UI/l	   –	  
	  
Table	  1:	  Laboratory	  findings	  in	  our	  patient	   	  
	  
During	   48	   h	   of	   fasting,	   no	   hypoglycaemia	   occurred.	   However,	   serum	   concentration	   of	   insulin	   and	  
c-­‐peptide	  progressively	  normalized	  (Fig.	  1).	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Subsequently,	  we	  performed	  an	  oral	  glucose	  tolerance	  test,	  which	  showed	  a	  very	  high	  concentration	  
of	   insulin	   in	  the	   late	  postprandial	  period	   in	  association	  with	  abnormally	   lower	  blood	  glucose	   levels	  
(Fig.	  2).	   	  
	  
	  
Figure	  2:	  blood	  glucose	  and	  insulin	  levels	  during	  oral	  glucose	  tolerance	  test	  
	  
Since	  no	  pancreatic	  masses	  or	  other	  suspicious	  lesions	  were	  detected	  by	  ultrasound	  of	  the	  abdomen,	  
or	   by	   thoracic	   and	   abdominal	   CT	   scans,	   we	   measured	   anti-­‐insulin	   antibodies	   (IAA),	   which	   were	  
present	   in	   high	   titres	   (IAA>100	   UI/ml).	   The	   presence	   of	   a	   high	   insulin	   autoantibody	   titre	   in	  
association	   with	   high	   levels	   of	   plasmatic	   insulin	   and	   hypoglycaemia	   without	   a	   history	   of	   insulin	  
administration	  confirmed	  the	  diagnosis	  of	  autoimmune	  hypoglycaemic	  syndrome	  (Hirata	  disease).	  
	  
Discussion	  
IAS	   or	   Hirata	   disease	   is	   very	   uncommon	   in	  Western	   countries:	   to	   date	   only	   60	   cases	   have	   been	  
reported	   in	   the	   non-­‐Asian	   population.	   It	   is	   clinically	   characterized	   by	   hyperinsulinaemic	  
hypoglycaemic	   episodes,	   often	   occurring	   in	   the	   late	   postprandial	   period.	   Fasting-­‐	   and	  
exercise-­‐induced	  hypoglycaemia	  has	  also	  been	  described.	   	  
IAS	  has	  been	  associated	  with	  many	  comorbidities	  and	  exposure	  to	  various	  medications.	  The	  diseases	  
most	   frequently	   associated	   with	   IAS	   are	   rheumatologic	   diseases	   such	   as	   systemic	   lupus	  
erythematosus	   (SLE)	   and	   systemic	   sclerosis,	   and	   haematological	   diseases	   in	   which	   there	   is	   an	  
improved	   production	   of	   immunoglobulins	   such	   as	   benign	   monoclonal	   gammopathy	   or	   multiple	  
myeloma3,4.	  Positive	  antinuclear	  antibodies,	  anti-­‐double-­‐stranded	  DNA	  and	  rheumatoid	  factors	  in	  the	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Many	  drugs	  have	  been	  associated	  with	   the	  development	  of	  Hirata	  disease.	   Lupsa	  et	   al.	   suggested	  
that	   in	  about	  47%	  of	   the	  non-­‐Asian	  patients,	   IAS	   seemed	   to	  be	   triggered	  by	  exposure	   to	  different	  
medications	   (captopril,	   penicillamine,	   pyritinol,	   imipenem,	   hydralazine,	   procainamide,	   isoniazide,	  
penicillin	   G)3.	   In	   the	   Japanese	   cases,	   a	   clear	   relation	   was	   demonstrated	   between	   medications	  
containing	  the	  sulphydryl	  group	  and	  the	  occurrence	  of	  the	  syndrome3.	  
Our	   patient	   did	   not	   show	   any	   rheumatologic	   or	   haematological	   disorder	   and	   had	   no	   history	   of	  
exposure	  to	  the	  drugs	  mentioned	  previously.	   	  
	  
Pathophysiologic	  considerations	   	  
Hirata	   disease	   is	   a	   rare	   cause	   of	   postprandial	   hypoglycaemia	   whose	   mechanism	   is	   to	   date	   not	  
completely	  understood.	   	  
Some	  authors	  have	  suggested	  a	  strong	  association	  between	  IAS	  and	  human	  leukocyte	  antigen	  (HLA)	  
haplotype.	  Most	  HLA-­‐DR4-­‐positive	  patients	  with	  IAS	  have	  HLA-­‐DRB1*0406,	  DRB1*0403	  or	  DRB10407.	  
Moreover,	   it	   has	   been	   suggested	   that	   agents	   such	   as	   sulphydryl	   compounds	   (methimazole,	  
carbimazole,	   penicillamine)	  may	   be	   related	   to	   the	   onset	   of	   the	   syndrome.	   It	   has	   been	   postulated	  
that	   the	   sulphydryl	   group	   interacts	  with	   the	   disulphide	   bonds	   in	   the	   insulin	  molecule,	  making	   the	  
insulin	  more	   immunogenic,	  either	  by	  hapten	   formation,	  or	  by	   cleavage	  of	   the	  disulphide	  bonds	  of	  
the	   insulin	  molecule.	   In	  most	   cases,	   discontinuing	   the	   sulphydryl	  medications	  was	   associated	  with	  
the	  remission	  of	  the	  hypoglycaemic	  episodes3.	  
It	  has	  been	  hypothesized	  that	  hypoglycaemia	  occurs	  through	  two	  main	  mechanisms:	   	  
	  
1. During	   the	   early	   postprandial	   period,	   the	   autoantibody	   immediately	   binds	   to	   insulin,	  
masking	   its	  bioactivity	   to	   its	   receptors	   in	   the	   liver	  and	   in	  peripheral	   tissues.	   This	   results	   in	  
hyperglycaemia	  and	  further	  insulin	  secretion.	   	  
2. During	   the	   late	   postprandial	   period,	   the	   autoantibody,	   because	   of	   low	   affinity,	   dissociates	  
from	   insulin	   and	   the	   free	   insulin	   exerts	   its	   intrinsic	   glucose-­‐lowering	   effect	   even	   in	   the	  
presence	  of	  normal	  levels	  of	  glucose,	  thus	  causing	  hypoglycaemia.	   	  
	  
The	   lower	   affinity	   and	   high	   binding	   capacity	   of	   IAA	  were	   described	   by	   Eguchi5	   in	   1998.	   Thus,	   the	  
autoantibody	   easily	   binds	   to	   insulin,	   but	   the	   insulin–autoantibody	   complex	  becomes	  unstable	   and	  
suddenly	  uncouples	  once	  plasma	   insulin	   increases	  above	   certain	   threshold	   levels.	   In	  our	   case,	   this	  
mechanism	   appears	   to	   have	   been	   present.	   In	   fact,	   in	   the	  OGTT	   test	  we	   observed	   that	   the	   insulin	  
levels	   rose	  rapidly	   in	   the	  early	  postprandial	  period,	   independently	  of	   the	  blood	  glucose	   levels,	  and	  
the	  glucose	  levels	  fell	  only	  in	  the	  late	  postprandial	  period	  (Fig.	  1).	  We	  also	  observed	  that	  there	  was	  a	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Therapeutic	  Approach	   	  
The	  most	  widely	  suggested	   therapeutic	   strategies	   for	  Hirata	  disease	  are	  educational	  measures	   like	  
frequent	  and	  small	  meals,	   low	  in	  simple	  carbohydrates.	  The	  use	  of	  alpha-­‐glucosidase	  inhibitors	  has	  
also	  been	  suggested.	  Both	  strategies	  are	  intended	  to	  decrease	  glucose-­‐dependent	  insulin	  secretion	  
in	   the	   first	   phase	   of	   the	   postprandial	   period,	   the	   former	   by	   reducing	   the	   glycaemic	   load	   and	   the	  
latter	  by	  delaying	  glucose	  absorption.	  Administration	  of	  corticosteroids	  or	  immunosuppressive	  drugs	  
in	  combination	  with	  plasmapheresis	   is	  another	  possible	  therapy,	  but	  clinical	  evidence	   is	   lacking	  for	  
these	  treatments.	   	  
In	   our	   patient,	   acarbose	   was	   administered	   without	   improvement	   of	   postprandial	   glycaemia.	   Our	  
choice,	  therefore,	  was	  to	  educate	  the	  patient	  to	  eat	  low-­‐carbohydrate	  meals,	  and	  this	  was	  enough	  to	  
avoid	  her	  postprandial	  symptoms.	   	  
In	   conclusion,	   Hirata	   disease	   is	   a	   very	   uncommon	   cause	   of	   hypoglycaemia,	   however	   it	   should	   be	  
considered	   in	   the	   differential	   diagnosis	   in	   any	   patient	   with	   hyperinsulinaemic	   hypoglycaemia	  
because	   a	   correct	   diagnosis	   may	   spare	   a	   hypoglycaemic	   patient	   from	   an	   unnecessary	   pancreatic	  




• Hirata	  disease	  is	  a	  rare	  case	  of	  hypoglycaemia.	  
• Frequently,	  a	  metabolic	  syndrome	  due	  to	  chronic	  hyperinsulinism	  is	  associated.	  
• A	  correct	  diagnosis	  may	  spare	  a	  patient	  from	  an	  unnecessary	  surgical	  procedure.	  
• Therapeutic	  strategies	  are	  focused	  on	  decreasing	  glucose-­‐dependent	  insulin	  secretion	  in	  the	  
first	  phase	  of	  the	  postprandial	  period.	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